Cargando…

Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis

OBJECTIVE: To investigate the difference of fatigue and pain in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS). METHODS: Data from the Modified Fatigue Impact Scale (MFIS) and Pain Effects Scale (PES) were compared between 51 NMOSD and 85 MS patients. Each s...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuda, Hiroki, Mori, Masahiro, Uzawa, Akiyuki, Uchida, Tomohiko, Ohtani, Ryohei, Kuwabara, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135064/
https://www.ncbi.nlm.nih.gov/pubmed/32251416
http://dx.doi.org/10.1371/journal.pone.0224419
_version_ 1783517970670026752
author Masuda, Hiroki
Mori, Masahiro
Uzawa, Akiyuki
Uchida, Tomohiko
Ohtani, Ryohei
Kuwabara, Satoshi
author_facet Masuda, Hiroki
Mori, Masahiro
Uzawa, Akiyuki
Uchida, Tomohiko
Ohtani, Ryohei
Kuwabara, Satoshi
author_sort Masuda, Hiroki
collection PubMed
description OBJECTIVE: To investigate the difference of fatigue and pain in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS). METHODS: Data from the Modified Fatigue Impact Scale (MFIS) and Pain Effects Scale (PES) were compared between 51 NMOSD and 85 MS patients. Each score was compared in each disease group with or without clinical abnormalities. Since almost no MS patients are without brain magnetic resonance imaging abnormalities, volumetry analysis by the Lesion Segmentation Tool and statistical parametric mapping 12 were added to obtain total lesion volume and intracranial volume in MS patients, and the correlations between total lesion volume/intracranial volume and each score were investigated. RESULTS: Compared to the MS group, the NMOSD group showed a higher PES score (median, 15.0 vs. 7.0, P = 0.045), no difference in MFIS, and an increased percentage of patients with extended spinal cord lesions (58.8% vs. 8.2%, P < 0.001). Moreover, NMOSD and MS patients with extended spinal cord lesions tended to demonstrate higher PES scores than those without. A positive correlation between MFIS and PES were found in patients with NMOSD and MS. On the other hand, MS patients showed a higher percentage of brain abnormalities (80.4% vs. 97.6%, P = 0.001) and a positive correlation between total lesion volume/intracranial volume and MFIS (Spearman’s ρ = 0.50, P = 0.033). CONCLUSIONS: The origin of fatigue may be associated with spinal cord lesions causing pain in NMOSD patients, but with brain lesions in MS patients.
format Online
Article
Text
id pubmed-7135064
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-71350642020-04-09 Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis Masuda, Hiroki Mori, Masahiro Uzawa, Akiyuki Uchida, Tomohiko Ohtani, Ryohei Kuwabara, Satoshi PLoS One Research Article OBJECTIVE: To investigate the difference of fatigue and pain in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS). METHODS: Data from the Modified Fatigue Impact Scale (MFIS) and Pain Effects Scale (PES) were compared between 51 NMOSD and 85 MS patients. Each score was compared in each disease group with or without clinical abnormalities. Since almost no MS patients are without brain magnetic resonance imaging abnormalities, volumetry analysis by the Lesion Segmentation Tool and statistical parametric mapping 12 were added to obtain total lesion volume and intracranial volume in MS patients, and the correlations between total lesion volume/intracranial volume and each score were investigated. RESULTS: Compared to the MS group, the NMOSD group showed a higher PES score (median, 15.0 vs. 7.0, P = 0.045), no difference in MFIS, and an increased percentage of patients with extended spinal cord lesions (58.8% vs. 8.2%, P < 0.001). Moreover, NMOSD and MS patients with extended spinal cord lesions tended to demonstrate higher PES scores than those without. A positive correlation between MFIS and PES were found in patients with NMOSD and MS. On the other hand, MS patients showed a higher percentage of brain abnormalities (80.4% vs. 97.6%, P = 0.001) and a positive correlation between total lesion volume/intracranial volume and MFIS (Spearman’s ρ = 0.50, P = 0.033). CONCLUSIONS: The origin of fatigue may be associated with spinal cord lesions causing pain in NMOSD patients, but with brain lesions in MS patients. Public Library of Science 2020-04-06 /pmc/articles/PMC7135064/ /pubmed/32251416 http://dx.doi.org/10.1371/journal.pone.0224419 Text en © 2020 Masuda et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Masuda, Hiroki
Mori, Masahiro
Uzawa, Akiyuki
Uchida, Tomohiko
Ohtani, Ryohei
Kuwabara, Satoshi
Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis
title Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis
title_full Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis
title_fullStr Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis
title_full_unstemmed Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis
title_short Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis
title_sort difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135064/
https://www.ncbi.nlm.nih.gov/pubmed/32251416
http://dx.doi.org/10.1371/journal.pone.0224419
work_keys_str_mv AT masudahiroki differenceinfatigueandpainbetweenneuromyelitisopticaspectrumdisorderandmultiplesclerosis
AT morimasahiro differenceinfatigueandpainbetweenneuromyelitisopticaspectrumdisorderandmultiplesclerosis
AT uzawaakiyuki differenceinfatigueandpainbetweenneuromyelitisopticaspectrumdisorderandmultiplesclerosis
AT uchidatomohiko differenceinfatigueandpainbetweenneuromyelitisopticaspectrumdisorderandmultiplesclerosis
AT ohtaniryohei differenceinfatigueandpainbetweenneuromyelitisopticaspectrumdisorderandmultiplesclerosis
AT kuwabarasatoshi differenceinfatigueandpainbetweenneuromyelitisopticaspectrumdisorderandmultiplesclerosis